Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

673 projects found matching your search criteria :

  1. Searching for the new lead structures for 5-HT7 serotonin receptor ligands with increased metabolic stability.

    Call: HARMONIA 7 , Panel: NZ7

    Principal investigator: Sabina Marta Podlewska

    Instytut Farmakologii PAN

  2. The Repository of the Polish 19th Century Translations of Shakespeare's Plays: the Resources, Translation Strategies and...

    Call: OPUS 9 , Panel: HS2

    Principal investigator: dr hab. Anna Urszula Cetera-Włodarczyk

    Uniwersytet Warszawski, Wydział Neofilologii

  3. Functional dissection of three alpha(1)-adrenergic receptor subtypes in the effects of antidepressant drugs: exploitatio...

    Call: OPUS 9 , Panel: NZ7

    Principal investigator: prof. Irena Maria Nalepa

    Instytut Farmakologii PAN

  4. Role of Pregnane-X-receptor (PXR) in the pathogenesis of primary sclerosing cholangitis (PSC)

    Call: OPUS 1 , Panel: NZ5

    Principal investigator: prof. Piotr Milkiewicz

    Pomorski Uniwersytet Medyczny w Szczecinie, Wydział Lekarski z Oddziałem Nauczania w Języku Angielskim

  5. Influence of autoimmune thyroid disease on the course of myasthenia gravis.

    Call: OPUS 1 , Panel: NZ5

    Principal investigator: dr hab. Anna Agnieszka Kostera-Pruszczyk

    Warszawski Uniwersytet Medyczny, I Wydział Lekarski

  6. Synthesis and binding studies of new podands based on 1,8-diaminocarbazole moiety

    Call: PRELUDIUM 9 , Panel: ST5

    Principal investigator: Krzysztof Marek Bąk

    Uniwersytet Warszawski, Wydział Chemii

  7. Extracellular nucleotide gradients as regulators of glioma cell motility

    Call: OPUS 9 , Panel: NZ3

    Principal investigator: dr hab. Paweł Pomorski

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  8. Metabolic profiling of HIF stabilizers, PPAR agonists and SARMs by means of UPLC-MS/MS.

    Call: PRELUDIUM 9 , Panel: ST4

    Principal investigator: Katarzyna Kowalczyk

    Uniwersytet Warszawski, Wydział Chemii

  9. Rational design and pharmacological characterization of chimeric cyclic opioid peptide analogs targeting multiple recept...

    Call: OPUS 9 , Panel: ST5

    Principal investigator: prof. Anna Ewa Janecka

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  10. The expression of gene and protein of androgen receptor in testis, pituitary and adrenal gland of turkeys (Meleagris gal...

    Call: PRELUDIUM 1 , Panel: NZ9

    Principal investigator: Jacek Kieżun

    Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Biologii

  11. Synthesis of new glutamate receptors antagonists and extensive investigation of their effect on tumor cells in the prese...

    Call: OPUS 9 , Panel: ST5

    Principal investigator: prof. Maria Wanda Bretner

    Politechnika Warszawska, Wydział Chemiczny

  12. Coactivators and corepressors of progesterone receptors as a regulators of progesterone influence on the trissues in the...

    Call: OPUS 9 , Panel: NZ4

    Principal investigator: dr Robert Jarosław Rękawiecki

    Instytut Rozrodu Zwierząt i Badań Żywności PAN

  13. Investigation of the effects and mechanisms of action of Deep Brain Stimulation in two animal models of treatment-resist...

    Call: OPUS 9 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

  14. Crosstalk between vitamin D receptor (VDR) and retinoic acid receptors (RARs) in hematopoiesis.

    Call: OPUS 9 , Panel: NZ4

    Principal investigator: prof. Ewa Teresa Marcinkowska

    Uniwersytet Wrocławski, Wydział Biotechnologii

  15. Changes in neurogenesis during withdrawal from nicotine self-administration in rats - role of serotonin (5-HT)2C recepto...

    Call: OPUS 9 , Panel: NZ4

    Principal investigator: dr Magdalena Joanna Zaniewska

    Instytut Farmakologii PAN

  16. Traizine 5-HT6 receptor ligands - new perspective for therapy of current civilization CNS-diseases

    Call: OPUS 9 , Panel: NZ7

    Principal investigator: dr hab. Jadwiga Handzlik

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  17. Reframed Image: Reception of Prints in the Kingdom of Poland from the End of the Fifteenth to the Beginning of the Seven...

    Call: OPUS 9 , Panel: HS2

    Principal investigator: dr hab. Grażyna Jurkowlaniec

    Uniwersytet Warszawski, Wydział Historyczny

  18. A Critical Edition of the Philosophical Anthology by Biernat of Lublin from MS 1717 of the Polish Academy of Sciences Li...

    Call: OPUS 1 , Panel: HS2

    Principal investigator: dr hab. Włodzimierz Olszaniec

    Uniwersytet Warszawski, Wydział Polonistyki

  19. The involvement of peroxisome proliferator-activated receptors (PPARs) in the regulation of cytokines synthesis in porci...

    Call: OPUS 9 , Panel: NZ9

    Principal investigator: prof. Iwona Urszula Bogacka

    Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Biologii i Biotechnologii

  20. The role of chemerin in the control of hypothalamic-pituitary-ovarian axis during the oestrous cycle and early pregnancy

    Call: OPUS 9 , Panel: NZ9

    Principal investigator: prof. Tadeusz Szczepan Kamiński

    Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Biologii i Biotechnologii

  21. RIG-I-like receptors and human cytomegalovirus infection in the placenta: too much of good things?

    Call: PRELUDIUM 9 , Panel: NZ6

    Principal investigator: Agnieszka Beata Jabłońska

    Instytut Biologii Medycznej PAN

  22. Porphyromonas gingivalis protein and its homologs from other periodontopathogens - a novel group of bacterial virulence ...

    Call: OPUS 9 , Panel: NZ6

    Principal investigator: prof. Teresa Barbara Olczak

    Uniwersytet Wrocławski, Wydział Biotechnologii

  23. Development of a method for the structure prediction of GPCRs complexes with agonists and antagonists, including the lig...

    Call: SONATA 1 , Panel: NZ2

    Principal investigator: dr Michał Koliński

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN